IGF1 and thromboangiitis obliterans: The findings reported herein indicate that pretreatment with linsitinib inhibited IGF-1-induced the phosphorylation of IGF-1Rβ, Akt at Ser473, and ERK, subsequently leading to the downregulation of the cell proliferation and HA secretion in the OFs of patients with TAO.